SEC Form 4 · accession 0001127602-17-006234
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · CRL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
George M Milne Jr.
Director
Period of report
Feb 14, 2017
Accepted (ET)
Feb 15, 2017 · 2:39 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001100682
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 14, 2017 | M | 10,710 | $30.44 | A | 39,240 | D | |
| Common Stock | Feb 14, 2017 | S | 10,710 | $86.52 | D | 28,530 | D | |
| Common Stock | holding | — | — | — | 1,000 | I | Held By Spouse |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (Right to Buy) | $30.44 | Feb 14, 2017 | M | 10,710 | D | May 7, 2011 | May 7, 2017 | Common Stock | 10,710 | 0 | D |
Explanation of responses
- F1This sale occurred pursuant to a 10b5-1 Trading Plan.